Does Sugar Make Antibiotics Worse for Your Gut — and What Does That Mean for Your Skin?

A landmark study published in Nature on September 30, 2026 found that eating sugar while taking antibiotics amplifies gut microbiome disruption by an additional 21% for every 100 grams of sugar consumed in the 48 hours before treatment — a finding that carries direct implications for skin health through the well-established gut-skin axis.

The research, led by scientists at NYU Langone Health, City of Hope, and Memorial Sloan Kettering Cancer Center, tracked 9,419 meals eaten by 173 hospitalized blood cancer patients and collected more than 1,000 stool samples to map microbiome changes in real time. The scale and resolution of the dataset make it one of the most detailed diet-microbiome studies ever conducted.

For anyone who has finished a course of antibiotics and noticed new breakouts, persistent dryness, or a flare of eczema, this research offers a plausible biological explanation — and a surprisingly simple dietary lever to pull.

What the Study Found at a Glance

Metric	Antibiotic alone	Antibiotic + high sugar	Source
Alpha diversity decline per 100 g sugar (48 h pre-treatment)	Baseline	Additional 21% reduction	ScienceDaily / NYU Langone
Enterococcus expansion in mice by day 3	Small increase	16.3-fold higher	ScienceDaily / NYU Langone
Enterococcus expansion in mice by day 6	Moderate increase	33.4-fold higher	PR Newswire / NYU Langone
Mortality signal in transplant patients (high vs. average sugar)	Reference	~12% higher risk (observational)	Times of India
Study population	173 patients, 9,419 meals, 1,009 stool samples	Same dataset	PubMed / bioRxiv preprint

These numbers come from a specific, high-risk population — patients undergoing hematopoietic cell (stem cell) transplantation — so they should not be extrapolated wholesale to someone taking a five-day course of amoxicillin for a sinus infection. The direction of the effect, however, is consistent across both the human observational data and the controlled mouse experiments, which strengthens the biological plausibility of the finding.

What Is the Gut Microbiome and Why Does It Matter for Skin?

The gut microbiome is the collective community of trillions of microorganisms — primarily bacteria, but also fungi, viruses, and archaea — that inhabit the human digestive tract and co-evolved with their human hosts over millions of years. This community is not passive. It regulates digestion, trains the immune system, produces short-chain fatty acids that nourish the gut lining, and communicates bidirectionally with the brain, liver, and skin.

The gut-skin axis is the bidirectional communication network linking the intestinal microbiome to skin physiology, mediated by immune signaling, circulating metabolites, and systemic inflammation. When the gut microbiome is disrupted — a state called dysbiosis — the downstream effects can include increased intestinal permeability ("leaky gut"), elevated systemic inflammatory markers, and altered sebum production, all of which have been associated with acne, eczema, rosacea, and psoriasis in observational research.

Alpha diversity, the measure used in the Nature study, counts how many different bacterial species are present in a given sample. Higher alpha diversity is generally considered a marker of a healthier, more resilient microbiome. When antibiotics reduce that diversity, the gut becomes more vulnerable — not just to opportunistic pathogens like Enterococcus faecium, but also to the kind of systemic inflammatory signaling that shows up on your face and scalp.

How Does Sugar Make Antibiotic Damage Worse?

The mechanism is not yet fully pinned down, but the researchers offer a coherent working hypothesis. Study co-author William Jogia explained that "the new work identifies dietary sugars as an amplifier of antibiotic-induced microbiome disruption, probably because the harmful bacteria that survive the antibiotics are benefiting from the dietary sugars that they can use to expand."

The sequence, as the researchers understand it, works like this: antibiotics kill or suppress a broad range of gut bacteria, including many beneficial species. This creates ecological space — fewer competitors for nutrients and colonization sites. Bacteria that are naturally resistant to the antibiotic being used, such as Enterococcus faecium, survive. If dietary sugar is abundant at this moment, those surviving bacteria can use it as fuel to proliferate rapidly, filling the vacuum before the beneficial microbiome has a chance to recover.

The mouse data illustrates this dramatically. Animals given the antibiotic biapenem alone showed a modest increase in Enterococcus. When sucrose was added to their diet, the Enterococcus population was 16.3-fold higher by day 3 and 33.4-fold higher by day 6 compared with the antibiotic-only condition.

Whether sugar directly feeds Enterococcus, weakens competing bacteria through some other route, or acts through a third mechanism in human patients remains an open question. The researchers are explicit about this uncertainty, and clinical trials are needed before firm dietary recommendations can be issued for the general public.

Who Was Studied — and Does It Apply to You?

The study population consisted of hospitalized patients undergoing hematopoietic cell transplantation (HCT) for blood cancers — a group that receives prolonged, broad-spectrum antibiotic courses and experiences some of the most severe microbiome disruption seen in clinical medicine. Co-senior author Jonathan Peled of Memorial Sloan Kettering noted that "especially in blood cancer patients, microbiome injury is associated with worse outcomes, including higher overall mortality and infections."

This context matters enormously. The magnitude of microbiome disruption in HCT patients is far greater than what a healthy adult experiences during a standard antibiotic course. The ecological pressure — weeks of broad-spectrum antibiotics, chemotherapy, and drastically altered nutrition — creates conditions that simply do not exist in routine outpatient antibiotic use.

That said, the biological mechanism the researchers propose is not inherently limited to immunocompromised patients. The mouse experiments, which used otherwise healthy animals, produced the same directional result. The Times of India's coverage noted that the evidence is strongest for the specific high-risk transplant population, not for every person taking antibiotics for a routine infection — a distinction worth keeping front of mind.

For people with skin conditions already linked to gut dysbiosis — acne, eczema, rosacea, seborrheic dermatitis — the findings are still worth taking seriously as a precautionary signal, even if the data does not yet support a prescriptive clinical recommendation.

What Is Enterococcus faecium and Why Should Skin-Focused Readers Care?

Enterococcus faecium is a gram-positive bacterium that normally lives in the gut at low levels without causing harm. It becomes problematic when the surrounding microbial community is depleted and it can expand unchecked. In immunocompromised patients, E. faecium is associated with bloodstream infections, urinary tract infections, and wound infections that are notoriously difficult to treat because many strains are resistant to vancomycin (VRE — vancomycin-resistant Enterococcus).

For skin health specifically, the concern is less about E. faecium directly infecting skin tissue in healthy people and more about what its overgrowth signals: a gut that has lost its diversity and its capacity to regulate systemic inflammation. A gut dominated by a single opportunistic species is not producing the short-chain fatty acids, tryptophan metabolites, and immune-regulatory signals that a diverse microbiome generates — and those signals are part of what keeps skin barrier function intact and inflammatory skin conditions in check.

The Nature commentary by Mengxi Du and Andrew T. Chan of Harvard Medical School and Massachusetts General Hospital framed the study's contribution precisely: diet can influence the severity of antibiotic-induced microbial disturbance, and understanding that influence is a key step toward designing microbiome-targeted therapies.

What Does This Mean for Skin Health Practically?

The gut-skin axis research base is still maturing, but several patterns have emerged consistently enough to inform practical decisions.

Antibiotic courses — even short ones — reliably reduce gut microbiome diversity. The reduction is usually temporary, but recovery can take weeks to months, and in some individuals the pre-antibiotic composition never fully returns. During that recovery window, the gut is more susceptible to colonization by opportunistic species and more prone to generating the kind of low-grade systemic inflammation that manifests as skin flares.

If the NYU Langone findings hold up in broader populations, adding high sugar intake to that window compounds the problem by giving surviving opportunistic bacteria a competitive advantage precisely when the microbiome is least able to resist them.

For someone managing acne, the implication is fairly direct. Sugar already has a well-documented relationship with acne through its effects on insulin and IGF-1 signaling, which drive sebum production and keratinocyte proliferation. The new research adds a second pathway — gut dysbiosis amplification — that may explain why some people notice breakouts specifically after antibiotic courses even when their diet has not otherwise changed.

For eczema and rosacea, conditions with stronger inflammatory and immune-dysregulation components, the gut-skin axis is even more directly implicated. A microbiome depleted by antibiotics and then further destabilized by sugar is less capable of producing the anti-inflammatory metabolites that help regulate skin immune responses.

None of this means antibiotics should be avoided when they are medically necessary. It means the dietary context around antibiotic use is worth paying attention to.

What Did the Researchers Recommend?

The researchers were careful not to overstate their findings. Co-senior author Jonas Schluter, PhD, of NYU Langone said: "Our study, which used more than 9,000 recorded meals, suggests that modifying diet during and after antibiotics, specifically by reducing sweets intake, could help with that."

The operative word is "suggests." The study is observational on the human side and controlled but animal-based on the mechanistic side. Jonathan Peled called for clinical trials to test whether short-term dietary changes actually improve clinical outcomes — those trials have not yet been conducted.

What the researchers do not recommend: stopping prescribed antibiotics, following an extremely restrictive diet, or treating this as a proven intervention. The practical takeaway, as Times of India summarized it, is simpler: during antibiotic treatment, limiting excess sweets and sugar-heavy foods may be sensible, particularly for people who are already at higher risk of microbiome disruption or skin flares.

Should You Take Probiotics During Antibiotics Instead?

This is a question the current study does not directly address, but it is a natural follow-on. Probiotic supplementation during and after antibiotic courses is widely discussed as a strategy for microbiome protection, and some clinical evidence supports its use for preventing antibiotic-associated diarrhea. The picture for broader microbiome restoration is more complicated — some research suggests that standard probiotic supplements may actually delay the return of the native microbiome after antibiotics.

The NYU Langone study points toward a different and more accessible lever: reducing the dietary substrate that allows harmful bacteria to outcompete recovering beneficial ones. This is a subtraction strategy rather than a supplementation strategy, which makes it lower-risk and easier to implement without clinical supervision.

Whether the two approaches — probiotic supplementation and sugar reduction — are complementary or redundant is a question for future trials. The evidence base for reducing sugar during antibiotic treatment is newer but mechanistically coherent; the evidence for probiotics is older but more mixed in terms of microbiome restoration outcomes.

How Does This Fit Into What We Already Know About Diet and the Gut-Skin Axis?

The relationship between diet, gut microbiome, and skin health is an active and changing research area. Several threads are now well-established enough to inform clinical thinking.

High-glycemic diets are associated with acne severity in multiple observational studies, with the mechanism running through insulin and IGF-1 signaling as well as gut microbiome composition. Fermented foods and dietary fiber are associated with greater gut microbiome diversity in large cohort studies. Gut dysbiosis has been documented in patients with eczema, psoriasis, and rosacea, though causality is difficult to establish in observational designs. The gut lining's integrity — maintained in part by short-chain fatty acids produced by beneficial gut bacteria — is a key determinant of how much inflammatory signaling leaks into systemic circulation and reaches the skin.

The new Nature study adds a specific, quantified, and mechanistically grounded data point to this picture: sugar during antibiotic treatment is not just a general dietary concern but a specific amplifier of microbiome disruption at a moment when the microbiome is already under maximum stress.

For readers actively managing skin conditions who take antibiotics periodically — whether for acne itself, for respiratory infections, or for other reasons — this finding is worth factoring into dietary choices during and immediately after treatment. It does not require dramatic changes. Reducing obvious sources of added sugar (sweetened beverages, desserts, sugary snacks) during the antibiotic course and for a few weeks afterward is a low-risk, biologically plausible strategy that aligns with the study's direction even while clinical trials are pending.

What Comes Next in This Research?

Marcel van den Brink, MD, PhD, chief physician executive at City of Hope, framed the broader significance: "Studies like this help us better understand how everyday factors, including diet, may affect a delicate balance that influences how patients respond to treatment, recover, and experience side effects."

The immediate next steps the researchers identified include designing randomized controlled trials to test whether reducing sugar intake during antibiotic treatment actually improves microbiome outcomes and clinical endpoints — including infection rates and, in cancer patients, transplant outcomes. They also want to clarify the precise mechanism: does sugar directly fuel Enterococcus faecium growth, does it weaken competing bacteria through some other route, or does it act through a third pathway?

For the skin health community, the parallel research agenda involves establishing whether the microbiome changes documented in this study — reduced alpha diversity, Enterococcus expansion — are sufficient to drive measurable changes in skin barrier function or inflammatory skin disease activity in otherwise healthy people. That work is likely years away from producing definitive answers, but the mechanistic framework is now considerably more concrete than it was before this study.

The study was published in Nature (DOI: 10.1038/s41586-026-11077-3) and was funded by multiple National Institutes of Health grants along with support from the Parker Institute for Cancer Immunotherapy, the Lymphoma Foundation, and the Starr Cancer Consortium, among others.

---

For related reading on how scalp and skin microbiome health intersects with product choices, see our guides to best amino acid scalp shampoos for daily use and best plumping and collagen-boosting serums.